Sirnaomics Closed Series C1 Financing of US$25 Million and Expands Clinical Programs of Anti-Fibrosis and Anti-Cancer RNAi Therapeutics2018-06-062018-06-08http://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.pngRedPepper Mergershttp://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.png200px200px
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.